Non-Invasive Fat Reduction Market Size

Non-Invasive Fat Reduction Market Analysis

The non-invasive fat reduction market is expected to register a CAGR of 10.5% over the forecast period.

The COVID-19 outbreak negatively impacted the non-invasive fat reduction market due to a halt in nonelective procedures during the pandemic. The market's growth was also impacted due to the disruption in the supply chain during lockdowns and a delay in the delivery of essential products required for the development of non-invasive fat reduction technology. However, after the easing of lockdown restrictions, there has been a surge of patients adopting aesthetic procedures. For instance, according to the International Society of Plastic Surgery (ISAPS) 2021 report, the number of non-surgical fat reduction procedures conducted globally was 560,464 in 2020, indicating a 21.1% increase compared to the previous year. Though the market was severely impacted during the initial phases of the pandemic, it started to recover after the easing of government regulations, growing at a normal pace.

The increasing adoption of non-invasive fat reduction procedures, growing prevalence of obesity, rising demand for minimally invasive procedures, and growing awareness of health risks are the major factors driving the market's growth. The increasing prevalence of obesity is one of the major factors propelling market growth. For instance, according to the World Obesity Federation 2022, about 1 billion people globally, including 1 in 5 women and 1 in 7 men, will be living with obesity by 2030. This figure indicates that there is a high burden of obesity in the world, which is likely to augment the growth of the market over the forecast period. The combination of non-invasive fat reduction treatment using high-focus ultrasound (HIFU), endermology, mesotherapy, and laser reduces resistant fat that does not respond to current treatment modalities of diet, exercise, and pharmacotherapy, as well as reduces body fat percentage. Thus, non-invasive fat reduction procedures are considered one of the effective treatments for obesity. Therefore, increasing cases of obesity are anticipated to boost the market over the forecast period.

The increasing number of initiatives from key market players for the launch of innovative cool sculpting devices may also propel the market over the forecast period. For instance, in January 2022, INDIBA launched ReBorn, a new and revolutionary fat loss device in the Spanish market. With its unique power LED technology, ReBorn can target fat cells while leaving surrounding tissue unaffected. It destroys adipocytes while leaving the skin unharmed. It also uses a proprietary cooling system to make treatments for patients much safer and more comfortable. In January 2021, Allergan Aesthetics, an AbbVie company, launched CoolSculpting Elite, a fat reduction system with applicators designed to complement the body's natural curves. CoolSculpting Elite is an FDA-approved device to treat visible fat bulges in different areas of the body. Hence, innovative product launches are expected to bolster the market's growth, along with the rising adoption of new devices in performing aesthetic procedures.

However, high treatment costs and side effects of laser are likely to hinder the market's growth over the forecast period.